المؤلفون: Savic, RM, Ruslami, R, Hibma, JE, Hesseling, A, Ramachandran, G, Ganiem, AR, Swaminathan, S, McIlleron, H, Gupta, A, Thakur, K, van Crevel, R, Aarnoutse, R, Dooley, KE

المصدر: Clinical Pharmacology & Therapeutics. 98(6)

مصطلحات موضوعية: Pharmacology and Pharmaceutical Sciences, Biomedical and Clinical Sciences, Clinical Trials and Supportive Activities, Tuberculosis, Orphan Drug, Infectious Diseases, Pediatric, Clinical Research, Rare Diseases, Neurosciences, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Infection, Good Health and Well Being, Administration, Intravenous, Administration, Oral, Adolescent, Adult, Age Factors, Antitubercular Agents, Body Weight, Child, Child, Preschool, Clinical Trials, Phase II as Topic, Computer Simulation, Drug Dosage Calculations, Humans, Infant, Levofloxacin, Models, Biological, Mycobacterium tuberculosis, Randomized Controlled Trials as Topic, Rifampin, Tuberculosis, Meningeal, Pharmacology & Pharmacy, Pharmacology and pharmaceutical sciences

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/7140x91j

المؤلفون: Hibma JE; Global Product Development, Pfizer Inc., La Jolla, California, USA., Jayachandran P; Global Product Development, Pfizer Inc., Cambridge, Massachusetts, USA., Neelakantan S; Global Product Development, Pfizer Inc., Cambridge, Massachusetts, USA., Harnisch LO; Global Product Development, Pfizer Inc., Sandwich, Kent, UK.

المصدر: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Mar; Vol. 12 (3), pp. 375-386. Date of Electronic Publication: 2023 Feb 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2163-8306 (Electronic) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Muscular Dystrophy, Duchenne*/drug therapy , Muscular Dystrophy, Duchenne*/genetics, Humans ; Male ; Disease Progression

المؤلفون: Hibma JE; Pfizer (Clinical Pharmacology Oncology), La Jolla, 10555 Science Center Drive, CB10-2727, San Diego, CA, 92121, USA. Jennifer.e.hibma@pfizer.com., O'Gorman M; Pfizer (Pharmacometrics Oncology), Groton, CT, USA., Nepal S; Pfizer (Statistics Oncology), Groton, CT, USA.; Independent Statistical Consultant, Schwenksville, PA, USA., Pawlak S; Pfizer (Clinical Development and Operations), New Haven, CT, USA., Ginman K; Pfizer (Clinical Development and Operations), South Lyon, MI, USA., Pithavala YK; Pfizer (Clinical Pharmacology Oncology), La Jolla, 10555 Science Center Drive, CB10-2727, San Diego, CA, 92121, USA.

المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 Jun; Vol. 89 (6), pp. 839.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Hibma JE; Pfizer (Clinical Pharmacology Oncology), La Jolla, 10555 Science Center Drive, CB10-2727, San Diego, CA, 92121, USA. Jennifer.e.hibma@pfizer.com., O'Gorman M; Pfizer (Pharmacometrics Oncology), Groton, CT, USA., Nepal S; Pfizer (Statistics Oncology), Groton, CT, USA.; Independent Statistical Consultant, Schwenksville, PA, USA., Pawlak S; Pfizer (Clinical Development and Operations), New Haven, CT, USA., Ginman K; Pfizer (Clinical Development and Operations), South Lyon, MI, USA., Pithavala YK; Pfizer (Clinical Pharmacology Oncology), La Jolla, 10555 Science Center Drive, CB10-2727, San Diego, CA, 92121, USA.

المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 Jan; Vol. 89 (1), pp. 71-81. Date of Electronic Publication: 2021 Oct 26.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Aminopyridines/*administration & dosage , Aminopyridines/*adverse effects , Aminopyridines/*pharmacokinetics , Anaplastic Lymphoma Kinase/*antagonists & inhibitors , Lactams/*administration & dosage , Lactams/*adverse effects , Lactams/*pharmacokinetics , Pyrazoles/*administration & dosage , Pyrazoles/*adverse effects , Pyrazoles/*pharmacokinetics, Administration, Oral ; Adult ; Aminopyridines/blood ; Biological Availability ; Healthy Volunteers ; Humans ; Injections, Intravenous ; Lactams/blood ; Male ; Middle Aged ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/blood ; Protein Kinase Inhibitors/pharmacokinetics ; Pyrazoles/blood

المؤلفون: Wenning L; Merck & Co., Inc., Kenilworth, New Jersey, USA., Pillai GC; Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa.; Pharmacometrics Africa, Cape Town, South Africa.; CP+ Associates GmbH, Basel, Switzerland., Knepper TC; Moffit Cancer Center, Tampa, Florida, USA., Ilic K; Shire, a Takeda Company, Lexington, Massachusetts, USA., Ali AM; Department of Bioengineering and Therapeutic Science, University of California, San Francisco, California, USA., Hibma JE; Pfizer, Inc., La Jolla, California, USA.

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Oct; Vol. 110 (4), pp. 946-951. Date of Electronic Publication: 2021 May 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Developing Countries* , Global Health*, Biomedical Research/*methods , Pharmacology, Clinical/*methods, Biomedical Research/education ; Career Choice ; Career Mobility ; Clinical Trials as Topic ; Humans ; Pharmacogenetics ; Pharmacology, Clinical/education

المؤلفون: Radtke KK; Dept of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Hibma JE; Dept of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Hesseling AC; Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Savic RM; Dept of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA.

المصدر: The European respiratory journal [Eur Respir J] 2021 Jan 05; Vol. 57 (1). Date of Electronic Publication: 2021 Jan 05 (Print Publication: 2021).

نوع المنشور: Letter; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

مواضيع طبية MeSH: Antibiotics, Antitubercular*/therapeutic use , Latent Tuberculosis*/drug therapy , Latent Tuberculosis*/prevention & control, Antitubercular Agents/therapeutic use ; Child ; Drug Therapy, Combination ; Humans ; Isoniazid/therapeutic use ; Rifampin/analogs & derivatives ; Rifampin/therapeutic use

المؤلفون: Hibma JE; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California., Radtke KK; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California., Dorman SE; School of Medicine, Johns Hopkins University, Baltimore, Maryland., Jindani A; St. George's, University of London, London, United Kingdom., Dooley KE; School of Medicine, Johns Hopkins University, Baltimore, Maryland., Weiner M; Department of Medicine, University of Texas Health Science Center, San Antonio, Texas.; South Texas Veterans Administration Medical Center, San Antonio, Texas; and., McIlleron HM; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California.

المصدر: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2020 Sep 15; Vol. 202 (6), pp. 866-877.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Systematic Review

بيانات الدورية: Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE

مواضيع طبية MeSH: Dose-Response Relationship, Drug*, Antibiotics, Antitubercular/*pharmacokinetics , Antibiotics, Antitubercular/*therapeutic use , Latent Tuberculosis/*drug therapy , Rifampin/*analogs & derivatives, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Rifampin/pharmacokinetics ; Rifampin/therapeutic use ; Young Adult

المؤلفون: Fostvedt LK; Pfizer Global Product Development, La Jolla, California, USA., Hibma JE; Pfizer Global Product Development, La Jolla, California, USA., Masters JC; Pfizer Global Product Development, La Jolla, California, USA., Vandendries E; Pfizer Global Product Development, Cambridge, Massachusetts, USA., Ruiz-Garcia A; Pfizer Global Product Development, La Jolla, California, USA.

المصدر: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2019 Nov; Vol. 106 (5), pp. 1006-1017. Date of Electronic Publication: 2019 Jul 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Models, Biological*, Aminoglycosides/*pharmacology , Aminoglycosides/*therapeutic use , Gemtuzumab/*pharmacology , Gemtuzumab/*therapeutic use , Leukemia, Myeloid, Acute/*drug therapy, Adolescent ; Aminoglycosides/administration & dosage ; Aminoglycosides/adverse effects ; Blood Platelets/drug effects ; Child ; Child, Preschool ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Drug Combinations ; Female ; Gemtuzumab/administration & dosage ; Gemtuzumab/adverse effects ; Humans ; Male ; Metabolic Clearance Rate ; Remission Induction ; Sialic Acid Binding Ig-like Lectin 3/biosynthesis ; Sialic Acid Binding Ig-like Lectin 3/drug effects ; United States

المؤلفون: Hibma JE; Pfizer Oncology, San Diego, CA, USA., Kantarjian HM; MD Anderson Cancer Center, Houston, TX, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Boni JP; Pfizer Oncology, Collegeville, PA, USA.

المصدر: British journal of clinical pharmacology [Br J Clin Pharmacol] 2019 Mar; Vol. 85 (3), pp. 590-600. Date of Electronic Publication: 2019 Jan 21.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*adverse effects , Inotuzumab Ozogamicin/*adverse effects , Long QT Syndrome/*diagnosis , Lymphoma, Non-Hodgkin/*drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/administration & dosage ; Dose-Response Relationship, Drug ; Electrocardiography/drug effects ; Female ; Humans ; Inotuzumab Ozogamicin/administration & dosage ; Long QT Syndrome/chemically induced ; Male ; Middle Aged ; Models, Biological ; Young Adult

المؤلفون: Hibma JE; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, 1550 4th St, RH 584, Box 2911, San Francisco, CA, 94158, USA.; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA, USA., Zur AA; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, 1550 4th St, RH 584, Box 2911, San Francisco, CA, 94158, USA., Castro RA; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, 1550 4th St, RH 584, Box 2911, San Francisco, CA, 94158, USA., Wittwer MB; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, 1550 4th St, RH 584, Box 2911, San Francisco, CA, 94158, USA., Keizer RJ; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, 1550 4th St, RH 584, Box 2911, San Francisco, CA, 94158, USA., Yee SW; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, 1550 4th St, RH 584, Box 2911, San Francisco, CA, 94158, USA., Goswami S; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, 1550 4th St, RH 584, Box 2911, San Francisco, CA, 94158, USA., Stocker SL; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, 1550 4th St, RH 584, Box 2911, San Francisco, CA, 94158, USA., Zhang X; Optivia Biotechnology Inc., Menlo Park, CA, USA., Huang Y; Optivia Biotechnology Inc., Menlo Park, CA, USA., Brett CM; Department of Anesthesiology, University of California San Francisco, San Francisco, CA, USA., Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, 1550 4th St, RH 584, Box 2911, San Francisco, CA, 94158, USA., Giacomini KM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, 1550 4th St, RH 584, Box 2911, San Francisco, CA, 94158, USA. kathy.giacomini@ucsf.edu.

المصدر: Clinical pharmacokinetics [Clin Pharmacokinet] 2016 Jun; Vol. 55 (6), pp. 711-21.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Ulcer Agents/*pharmacology , Famotidine/*pharmacology , Hypoglycemic Agents/*pharmacokinetics , Metformin/*pharmacokinetics , Organic Cation Transport Proteins/*antagonists & inhibitors, Adult ; Area Under Curve ; Blood Glucose ; Creatinine/blood ; Creatinine/urine ; Cross-Over Studies ; Dose-Response Relationship, Drug ; Female ; Humans ; Male ; Young Adult